search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INFECTION PREVENTION


to 35 percent in 2020. There were also fewer IPs who are reg- istered nurses, down 75 percent in 2019 to 49 percent in 2020. The results of a CBIC marketing research study found those IPs who were certified “demonstrated professional competency and increased career growth.” Those surveyed also reported that “certification improved the practice of IPC, as well as improved patient care and patient safety.” On the other hand, respondents “were less positive as to whether certification would lead to monetary compensation and an increase in organizational recognition.” 2


Roles and responsibilities The majority of IPs surveyed (33 percent) said they report directly to the VP/Director, Quality/Risk Management/ Chief Quality Officer, followed by VP/Director/Manager/ Chief Nursing Officer (CNO) (21 percent), CEO/COO/CFO/ Hospital Administration (15 percent) and Director/Manager Infection Prevention (12 percent). Fewer IPs reported spending 100 percent of their work time in infection prevention, which could indicate that the IP’s role is expanding. In 2020, only 32 percent of those surveyed said all of their time was spent in IP, compared with 46 percent in 2019. The most reported work categories for IPs outside of infection prevention are: National Healthcare Safety Net- work (NHSN) (27 percent), employee/occupational health (23 percent), education/compliance (18 percent), quality performance management (15 percent), disaster/bioterrorism preparedness (13 percent) and patient safety (12 percent). With the shift to value-based purchasing and payments, including payment reductions under the Centers for Medicare


& Medicaid Services (CMS) Hospital-Acquired Condition (HAC) Reduction Program, healthcare organizations need IPs to take an active role in product selection. The majority of IPs surveyed (63 percent) said they are members of product evaluation committees.


With regards to their role in product evaluation, the highest response percentages were determining the need for a product (56 percent), product safety evaluation (50 percent), process improvement (45 percent) and product testing (42 percent).


Trends and Technologies Each year Healthcare Purchasing News surveys IPs on some of the latest trends and technologies impacting their role in patient care and safety. Below is a summary of this year’s findings.


Antimicrobial stewardship and prescription safety On September 30, 2019, CMS published a final rule that re- quires all critical access hospitals (CAH) that participate in Medicare or Medicaid to develop and implement an antibiotic stewardship program. The rule states: “The CAH must have active facility-wide programs, for the surveillance, prevention, and control of HAIs and other infectious diseases and for the optimization of antibiotic use through stew- ardship. The programs must demonstrate adherence to nationally recognized infection prevention and control guidelines, as well as to best practices for improving antibiotic use where applicable, and for reducing the development and transmission of HAIs and antibiotic-resistant organisms. Infection prevention and control problems and antibiotic use issues identified in the programs must be


Veteran Owned • Made in America


drapes • medication labels • surgical markers • urinals • neutral zones


viscotcs@viscot.com • www.viscot.com • 800.221.0658 Our team is standing by to help


viscotcs@viscot.com • www.viscot.com • 800.221.0658


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58